Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019994695> ?p ?o ?g. }
- W2019994695 endingPage "843" @default.
- W2019994695 startingPage "838" @default.
- W2019994695 abstract "To test the delivery of prostaglandin E1 (PGE1) in novel transdermal liposomal formulations through foreskin and to determine whether there is a correlation between in vitro transdermal absorption and in vivo efficacy in patients with erectile dysfunction.The in vitro transdermal absorption of PGE1 through excised foreskin from liposomal formulations was tested in diffusion cells using radiolabeled drug. The in vivo studies were carried out on 5 patients (aged 54 to 70 years) in a double-blind, placebo-controlled fashion. The patients were treated topically on the penis with three different active formulations containing 0.05% PGE1 and a placebo at least 1 week apart. The change in systolic peak flow velocities in the cavernosal arteries after treatment was monitored by duplex color Doppler ultrasonography with spectral analysis every 15 minutes for 1 hour.The permeability coefficient (Kp) of PGE1 from the three liposomal formulations tested was found to be 0. 10, 1.66, and 3.82 x 10(-4) cm/hr, respectively. Peak systolic flow velocities in the deep cavernosal arteries of patients increased significantly compared with preapplication values (0.05 < P < or = 0.1) after application of two of the transdermal liposomal PGE1 formulations tested (the two with the highest Kp). The highest mean peak systolic flow velocity was achieved at 45 minutes after application of the formulations. The most effective formulation in this study resulted in a sevenfold increase in mean flow velocity compared with baseline values.Topical application of PGE1 in a novel transdermal liposomal delivery system can enhance penetration of the drug into the deep cavernosal bodies and increase peak systolic flow velocities in patients with erectile dysfunction. The transdermal flux and permeability of PGE1 measured in vitro correlate well with the color Doppler ultrasound results in patients. The efficacy of a formulation in the development process may be predicted from in vitro absorption studies." @default.
- W2019994695 created "2016-06-24" @default.
- W2019994695 creator A5012059374 @default.
- W2019994695 creator A5019437270 @default.
- W2019994695 creator A5040345301 @default.
- W2019994695 creator A5062327416 @default.
- W2019994695 creator A5091686827 @default.
- W2019994695 date "1998-11-01" @default.
- W2019994695 modified "2023-09-27" @default.
- W2019994695 title "Liposome encapsulated prostaglandin E1 in erectile dysfunction: correlation between in vitro delivery through foreskin and efficacy in patients" @default.
- W2019994695 cites W134619012 @default.
- W2019994695 cites W197388660 @default.
- W2019994695 cites W1999676646 @default.
- W2019994695 cites W200012332 @default.
- W2019994695 cites W2047464598 @default.
- W2019994695 cites W2055995105 @default.
- W2019994695 cites W2060834668 @default.
- W2019994695 cites W2080637610 @default.
- W2019994695 cites W2133927893 @default.
- W2019994695 cites W2157388128 @default.
- W2019994695 cites W2167833794 @default.
- W2019994695 cites W2292781521 @default.
- W2019994695 cites W2312845168 @default.
- W2019994695 cites W2410907529 @default.
- W2019994695 cites W2412275604 @default.
- W2019994695 cites W4230764065 @default.
- W2019994695 cites W50222105 @default.
- W2019994695 doi "https://doi.org/10.1016/s0090-4295(98)00299-4" @default.
- W2019994695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9801110" @default.
- W2019994695 hasPublicationYear "1998" @default.
- W2019994695 type Work @default.
- W2019994695 sameAs 2019994695 @default.
- W2019994695 citedByCount "21" @default.
- W2019994695 countsByYear W20199946952013 @default.
- W2019994695 countsByYear W20199946952014 @default.
- W2019994695 countsByYear W20199946952016 @default.
- W2019994695 countsByYear W20199946952018 @default.
- W2019994695 countsByYear W20199946952019 @default.
- W2019994695 countsByYear W20199946952021 @default.
- W2019994695 countsByYear W20199946952022 @default.
- W2019994695 crossrefType "journal-article" @default.
- W2019994695 hasAuthorship W2019994695A5012059374 @default.
- W2019994695 hasAuthorship W2019994695A5019437270 @default.
- W2019994695 hasAuthorship W2019994695A5040345301 @default.
- W2019994695 hasAuthorship W2019994695A5062327416 @default.
- W2019994695 hasAuthorship W2019994695A5091686827 @default.
- W2019994695 hasConcept C126322002 @default.
- W2019994695 hasConcept C126894567 @default.
- W2019994695 hasConcept C142724271 @default.
- W2019994695 hasConcept C150903083 @default.
- W2019994695 hasConcept C171250308 @default.
- W2019994695 hasConcept C185154212 @default.
- W2019994695 hasConcept C192562407 @default.
- W2019994695 hasConcept C204787440 @default.
- W2019994695 hasConcept C205679159 @default.
- W2019994695 hasConcept C207001950 @default.
- W2019994695 hasConcept C27081682 @default.
- W2019994695 hasConcept C2779837120 @default.
- W2019994695 hasConcept C2779929075 @default.
- W2019994695 hasConcept C2780816001 @default.
- W2019994695 hasConcept C2781140480 @default.
- W2019994695 hasConcept C42219234 @default.
- W2019994695 hasConcept C54355233 @default.
- W2019994695 hasConcept C71924100 @default.
- W2019994695 hasConcept C79191276 @default.
- W2019994695 hasConcept C81885089 @default.
- W2019994695 hasConcept C86803240 @default.
- W2019994695 hasConcept C98274493 @default.
- W2019994695 hasConceptScore W2019994695C126322002 @default.
- W2019994695 hasConceptScore W2019994695C126894567 @default.
- W2019994695 hasConceptScore W2019994695C142724271 @default.
- W2019994695 hasConceptScore W2019994695C150903083 @default.
- W2019994695 hasConceptScore W2019994695C171250308 @default.
- W2019994695 hasConceptScore W2019994695C185154212 @default.
- W2019994695 hasConceptScore W2019994695C192562407 @default.
- W2019994695 hasConceptScore W2019994695C204787440 @default.
- W2019994695 hasConceptScore W2019994695C205679159 @default.
- W2019994695 hasConceptScore W2019994695C207001950 @default.
- W2019994695 hasConceptScore W2019994695C27081682 @default.
- W2019994695 hasConceptScore W2019994695C2779837120 @default.
- W2019994695 hasConceptScore W2019994695C2779929075 @default.
- W2019994695 hasConceptScore W2019994695C2780816001 @default.
- W2019994695 hasConceptScore W2019994695C2781140480 @default.
- W2019994695 hasConceptScore W2019994695C42219234 @default.
- W2019994695 hasConceptScore W2019994695C54355233 @default.
- W2019994695 hasConceptScore W2019994695C71924100 @default.
- W2019994695 hasConceptScore W2019994695C79191276 @default.
- W2019994695 hasConceptScore W2019994695C81885089 @default.
- W2019994695 hasConceptScore W2019994695C86803240 @default.
- W2019994695 hasConceptScore W2019994695C98274493 @default.
- W2019994695 hasIssue "5" @default.
- W2019994695 hasLocation W20199946951 @default.
- W2019994695 hasLocation W20199946952 @default.
- W2019994695 hasOpenAccess W2019994695 @default.
- W2019994695 hasPrimaryLocation W20199946951 @default.
- W2019994695 hasRelatedWork W1982254958 @default.
- W2019994695 hasRelatedWork W2002583647 @default.
- W2019994695 hasRelatedWork W2015571462 @default.